GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Change In Inventory

Curocell (XKRX:372320) Change In Inventory : ₩0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Change In Inventory?

Curocell's change in inventory for the quarter that ended in Mar. 2025 was ₩0.00 Mil. It means Curocell's inventory stayed the same from Dec. 2024 to Mar. 2025 .

Curocell's change in inventory for the fiscal year that ended in Dec. 2024 was ₩0.00 Mil. It means Curocell's inventory stayed the same from Dec. 2023 to Dec. 2024 .

Curocell's Total Inventories for the quarter that ended in Mar. 2025 was ₩0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Curocell Change In Inventory Historical Data

The historical data trend for Curocell's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Change In Inventory Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Inventory
Get a 7-Day Free Trial - - - - -

Curocell Quarterly Data
Dec19 Dec20 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Curocell Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curocell  (XKRX:372320) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Curocell's Days Inventory for the quarter that ended in is calculated as:

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Curocell's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Curocell's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curocell Change In Inventory Related Terms

Thank you for viewing the detailed overview of Curocell's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell Business Description

Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell Headlines

No Headlines